Dearborn Partners LLC Sells 210 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Dearborn Partners LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,060 shares of the financial services provider’s stock after selling 210 shares during the period. Dearborn Partners LLC’s holdings in iShares Biotechnology ETF were worth $882,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Highline Wealth Partners LLC acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $30,000. Bbjs Financial Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at $31,000. Ashton Thomas Securities LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Voisard Asset Management Group Inc. acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $59,000. Finally, Aptus Capital Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 36.5% during the 3rd quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after buying an additional 114 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 4.8 %

iShares Biotechnology ETF stock opened at $133.38 on Friday. iShares Biotechnology ETF has a 12-month low of $116.70 and a 12-month high of $150.57. The business’s 50-day moving average price is $144.49 and its two-hundred day moving average price is $141.59.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.